Other
Reviewed and published by trentmaziarz, July 11, 2026. Discovered and drafted by our automated research pipeline.
UMass Memorial Health tested a real-time AI system during live endoscopy procedures that analyzed video footage to classify bile duct narrowings as cancerous or benign, as part of the SMART-AI clinical trial.
Details
The SMART-AI trial, led by a physician at UMass Chan Medical School and conducted using patient procedures at UMass Memorial Health, involved connecting an AI-equipped computer directly to a cholangioscope (a tiny camera used inside bile ducts). The AI analyzed the live video stream frame-by-frame, classifying areas as malignant, suspicious, benign, or uninformative in real time. In a 41-patient trial, the AI achieved 87.8% accuracy in classifying biliary strictures, compared to 67.4% for standard sampling techniques and 63.1% for visual assessment by experienced endoscopists. Results were published in April 2026 in Clinical Gastroenterology and Hepatology.
Products affected
SMART-AI cholangioscopy system (research tool developed at UMass Chan)
Sources & Evidence
Other practices by UMass Memorial Health
OtherUMass Memorial Health offers MRI scans through its Shields Health partnership that use AI-powered image reconstruction technology to reduce scan time while maintaining image quality.ProductivityUMass Memorial Health uses AI to automatically assign billing codes for radiology procedures, raising its automated coding rate in the radiology department from approximately 70% to 86%.Data AnalysisUMass Memorial Health integrated AEYE Health's AEYE-DS, an autonomous AI diagnostic tool, into its electronic medical record system in 2024 to screen diabetic patients for eye disease during primary care visits.
Have evidence about UMass Memorial Health's AI practices? Submit a report.
Report a Sighting →